BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23328335)

  • 1. Pill counts and pill rental: unintended entrepreneurial opportunities.
    Viscomi CM; Covington M; Christenson C
    Clin J Pain; 2013 Jul; 29(7):623-4. PubMed ID: 23328335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving use of narcotics for nonmalignant chronic pain: a lesson from Community Care of North Carolina.
    Bujold E; Huff J; Staton EW; Pace WD
    J Opioid Manag; 2012; 8(6):363-7. PubMed ID: 23264314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating an Epidemic of Prescription Opioid Abuse.
    Pon D; Awuah K; Curi D; Okyere E; Stern CS
    J Calif Dent Assoc; 2015 Nov; 43(11):673-8. PubMed ID: 26798885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for potential prescription opioid misuse in a michigan medicaid population.
    Braker LS; Reese AE; Card RO; Van Howe RS
    Fam Med; 2009; 41(10):729-34. PubMed ID: 19882397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of opioids.
    Stanos S
    J Fam Pract; 2007 Feb; 56(2 Suppl Pain):23-32. PubMed ID: 17270115
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid management of pain: the impact of the prescription opioid abuse epidemic.
    Rauenzahn S; Del Fabbro E
    Curr Opin Support Palliat Care; 2014 Sep; 8(3):273-8. PubMed ID: 25004173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the role of Urine Drug Testing (UDT) in the management of chronic non-cancer pain with opioids?
    Schonwald G
    Pain Med; 2012 Jul; 13(7):853-6. PubMed ID: 22804903
    [No Abstract]   [Full Text] [Related]  

  • 13. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.
    Woolf CJ; Hashmi M
    Curr Opin Investig Drugs; 2004 Jan; 5(1):61-6. PubMed ID: 14983975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Source of drugs for prescription opioid analgesic abusers: a role for the Internet?
    Cicero TJ; Shores CN; Paradis AG; Ellis MS
    Pain Med; 2008 Sep; 9(6):718-23. PubMed ID: 18816331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire by Holmes et al.
    Passik SD; Kirsh KL
    Pain Pract; 2006 Jun; 6(2):69-71. PubMed ID: 17309712
    [No Abstract]   [Full Text] [Related]  

  • 17. An opioid screening instrument: long-term evaluation of the utility of the Pain Medication Questionnaire.
    Holmes CP; Gatchel RJ; Adams LL; Stowell AW; Hatten A; Noe C; Lou L
    Pain Pract; 2006 Jun; 6(2):74-88. PubMed ID: 17309714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of oral fluid in compliance monitoring of opioid medications.
    Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D
    Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment.
    Inciardi JA; Surratt HL; Cicero TJ; Beard RA
    Pain Med; 2009 Apr; 10(3):537-48. PubMed ID: 19416440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse.
    Knisely JS; Wunsch MJ; Cropsey KL; Campbell ED
    J Subst Abuse Treat; 2008 Dec; 35(4):380-6. PubMed ID: 18657935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.